{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:36:26Z","timestamp":1790674586510,"version":"4.1.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["480176\/2013-2"],"award-info":[{"award-number":["480176\/2013-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12035-018-0890-6","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T08:24:57Z","timestamp":1517387097000},"page":"7201-7215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington\u2019s Disease Mice"],"prefix":"10.1007","volume":"55","author":[{"given":"Victor Silva","family":"da Fons\u00eaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 R.","family":"da Silva Colla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"de Paula Nascimento-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelini","family":"Pl\u00e1cido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Macedo","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gil-Mohapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Brocardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"issue":"3","key":"890_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"S-H Li","year":"2004","unstructured":"Li S-H, Li X-J (2004) Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20(3):146\u2013154. https:\/\/doi.org\/10.1016\/j.tig.2004.01.008","journal-title":"Trends Genet"},{"issue":"10","key":"890_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. EMBO Rep 5(10):958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250","journal-title":"EMBO Rep"},{"key":"890_CR3","volume-title":"Huntington\u2019s disease","author":"GP Bates","year":"2002","unstructured":"Bates GP, Harper PS, Jones AL (2002) Huntington\u2019s disease. Oxford University Press, Oxford, UK"},{"issue":"2","key":"890_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.psychres.2010.04.030","volume":"178","author":"LJ Beglinger","year":"2010","unstructured":"Beglinger LJ, O\u2019Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS, Huntington Study Group I (2010) Earliest functional declines in Huntington disease. Psychiatry Res 178(2):414\u2013418","journal-title":"Psychiatry Res"},{"issue":"12","key":"890_CR5","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/jnnp.47.12.1283","volume":"47","author":"M Schoenfeld","year":"1984","unstructured":"Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E (1984) Increased rate of suicide among patients with Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 47(12):1283\u20131287. https:\/\/doi.org\/10.1136\/jnnp.47.12.1283","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"890_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/jmg.30.4.293","volume":"30","author":"L Maio Di","year":"1993","unstructured":"Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington\u2019s disease. J Med Genet 30(4):293\u2013295. https:\/\/doi.org\/10.1136\/jmg.30.4.293","journal-title":"J Med Genet"},{"issue":"6","key":"890_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/WNL.0b013e3181eccfa2","volume":"75","author":"K Duff","year":"2010","unstructured":"Duff K, Paulsen J, Mills J, Beglinger L, Moser D, Smith M, Langbehn D, Stout J et al (2010) Mild cognitive impairment in prediagnosed Huntington disease. Neurology 75(6):500\u2013507. https:\/\/doi.org\/10.1212\/WNL.0b013e3181eccfa2","journal-title":"Neurology"},{"issue":"4","key":"890_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E Duijn Van","year":"2007","unstructured":"Van Duijn E, Kingma E, Van der Mast R (2007) Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatr Clin Neurosci 19(4):441\u2013448","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"6","key":"890_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/archneur.1996.00550060035012","volume":"53","author":"B Zappacosta","year":"1996","unstructured":"Zappacosta B, Monza D, Meoni C, Austoni L, Soliveri P, Gellera C, Alberti R, Mantero M et al (1996) Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or cag repeat length in Huntington\u2019s disease. Arch Neurol 53(6):493\u2013497. https:\/\/doi.org\/10.1001\/archneur.1996.00550060035012","journal-title":"Arch Neurol"},{"issue":"12","key":"890_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","volume":"62","author":"K Duff","year":"2007","unstructured":"Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC, Group P-HIotHS (2007) Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study. Biol Psychiatry 62(12):1341\u20131346","journal-title":"Biol Psychiatry"},{"issue":"9","key":"890_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","volume":"78","author":"CL Julien","year":"2007","unstructured":"Julien CL, Thompson JC, Wild S, Yardumian P, Snowden JS, Turner G, Craufurd D (2007) Psychiatric disorders in preclinical Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 78(9):939\u2013943. https:\/\/doi.org\/10.1136\/jnnp.2006.103309","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"890_CR12","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, Van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12(13):1555\u20131567. https:\/\/doi.org\/10.1093\/hmg\/ddg169","journal-title":"Hum Mol Genet"},{"issue":"24","key":"890_CR13","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","volume":"14","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR (2005) Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14(24):3823\u20133835. https:\/\/doi.org\/10.1093\/hmg\/ddi407","journal-title":"Hum Mol Genet"},{"issue":"4","key":"890_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/brain\/awp006","volume":"132","author":"MA Pouladi","year":"2009","unstructured":"Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Peters\u00e9n \u00c5, Hayden MR (2009) Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132(4):919\u2013932","journal-title":"Brain"},{"issue":"16","key":"890_CR15","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 25(16):4169\u20134180. https:\/\/doi.org\/10.1523\/JNEUROSCI.0590-05.2005","journal-title":"J Neurosci"},{"issue":"2","key":"890_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2010.09.012","volume":"41","author":"JM Simpson","year":"2011","unstructured":"Simpson JM, Gil-Mohapel J, Pouladi MA, Ghilan M, Xie Y, Hayden MR, Christie BR (2011) Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease. Neurobiol Dis 41(2):249\u2013260. https:\/\/doi.org\/10.1016\/j.nbd.2010.09.012","journal-title":"Neurobiol Dis"},{"issue":"5529","key":"890_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science (New York, NY) 293(5529):493\u2013498. https:\/\/doi.org\/10.1126\/science.1059581","journal-title":"Science (New York, NY)"},{"issue":"1","key":"890_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, De Mey J, MacDonald ME et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118(1):127\u2013138. https:\/\/doi.org\/10.1016\/j.cell.2004.06.018","journal-title":"Cell"},{"issue":"11","key":"890_CR19","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"75","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in Rat Brain by Chronic Electroconvulsive Seizure and Antidepressant Drug Treatments. J Neurosci 75(11):7539\u20137547","journal-title":"J Neurosci"},{"issue":"12","key":"890_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.tips.2005.10.005","volume":"26","author":"JE Malberg","year":"2005","unstructured":"Malberg JE, Blendy JA (2005) Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 26(12):631\u2013638. https:\/\/doi.org\/10.1016\/j.tips.2005.10.005","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"890_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0006-3223(00)00228-6","volume":"47","author":"TM Madsen","year":"2000","unstructured":"Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A (2000) Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47(12):1043\u20131049. https:\/\/doi.org\/10.1016\/S0006-3223(00)00228-6","journal-title":"Biol Psychiatry"},{"issue":"3","key":"890_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hipo.20156","volume":"16","author":"JL Warner-Schmidt","year":"2006","unstructured":"Warner-Schmidt JL, Duman RS (2006) Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16(3):239\u2013249. https:\/\/doi.org\/10.1002\/hipo.20156","journal-title":"Hippocampus"},{"issue":"5634","key":"890_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301(5634):805\u2013809. https:\/\/doi.org\/10.1126\/science.1083328","journal-title":"Science"},{"issue":"4","key":"890_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","volume":"62","author":"DJ David","year":"2009","unstructured":"David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA et al (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression. Neuron 62(4):479\u2013493. https:\/\/doi.org\/10.1016\/j.neuron.2009.04.017","journal-title":"Neuron"},{"issue":"1","key":"890_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","volume":"210","author":"Q Peng","year":"2008","unstructured":"Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model. Exp Neurol 210(1):154\u2013163. https:\/\/doi.org\/10.1016\/j.expneurol.2007.10.015","journal-title":"Exp Neurol"},{"issue":"3","key":"890_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/10611860903318134","volume":"18","author":"SR Alcal\u00e1-Barraza","year":"2010","unstructured":"Alcal\u00e1-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH, McLoon LK (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18(3):179\u2013190. https:\/\/doi.org\/10.3109\/10611860903318134","journal-title":"J Drug Target"},{"issue":"2","key":"890_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11095-011-0572-9","volume":"29","author":"SR Vaka","year":"2012","unstructured":"Vaka SR, Murthy SN, Balaji A, Repka MA (2012) Delivery of brain-derived neurotrophic factor via nose-to-brain pathway. Pharm Res 29(2):441\u2013447. https:\/\/doi.org\/10.1007\/s11095-011-0572-9","journal-title":"Pharm Res"},{"issue":"4","key":"890_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1503\/jpn.120050","volume":"38","author":"AL Takatsu-Coleman","year":"2013","unstructured":"Takatsu-Coleman AL, Patti CL, Zanin KA, Zager A, Carvalho RC, Bor\u00e7oi AR, Ceccon LM, Berro LF et al (2013) Short-term social isolation induces depressive-like behaviour and reinstates the retrieval of an aversive task: mood-congruent memory in male mice? J Psychiatr Neurosci: JPN 38(4):259\u2013268. https:\/\/doi.org\/10.1503\/jpn.120050","journal-title":"J Psychiatr Neurosci: JPN"},{"issue":"4","key":"890_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s002130050472","volume":"134","author":"JM Weiss","year":"1997","unstructured":"Weiss JM (1997) Does decreased sucrose intake indicate loss of preference in CMS model? Psychopharmacology 134(4):368\u2013370. https:\/\/doi.org\/10.1007\/s002130050472","journal-title":"Psychopharmacology"},{"key":"890_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pbb.2016.10.004","volume":"150-151","author":"VB Neis","year":"2016","unstructured":"Neis VB, Bettio LE, Moretti M, Rosa PB, Ribeiro CM, Freitas AE, Goncalves FM, Leal RB et al (2016) Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice. Pharmacol Biochem Behav 150-151:108\u2013114. https:\/\/doi.org\/10.1016\/j.pbb.2016.10.004","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"890_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52(2):90\u2013110. https:\/\/doi.org\/10.1159\/000087097","journal-title":"Neuropsychobiology"},{"issue":"4","key":"890_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1017\/S1461145705005316","volume":"8","author":"MP Kaster","year":"2005","unstructured":"Kaster MP, Rosa AO, Santos AR, Rodrigues AL (2005) Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Intern J Neuropsychopharmacol\/Off Sci J Collegium Internationale Neuropsychopharmacologicum 8(4):601\u2013606. https:\/\/doi.org\/10.1017\/S1461145705005316","journal-title":"Intern J Neuropsychopharmacol\/Off Sci J Collegium Internationale Neuropsychopharmacologicum"},{"issue":"3","key":"890_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367\u2013370. https:\/\/doi.org\/10.1007\/BF00428203","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"890_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","volume":"463","author":"L Prut","year":"2003","unstructured":"Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463(1\u20133):3\u201333. https:\/\/doi.org\/10.1016\/S0014-2999(03)01272-X","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"890_CR35","first-page":"327","volume":"229","author":"R Porsolt","year":"1977","unstructured":"Porsolt R, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"1","key":"890_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u2013275","journal-title":"J Biol Chem"},{"issue":"3","key":"890_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","volume":"182","author":"T Scholzen","year":"2000","unstructured":"Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182(3):311\u2013322. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","journal-title":"J Cell Physiol"},{"issue":"1","key":"890_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0165-0270(02)00007-9","volume":"115","author":"N Kee","year":"2002","unstructured":"Kee N, Sivalingam S, Boonstra R, Wojtowicz J (2002) The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 115(1):97\u2013105. https:\/\/doi.org\/10.1016\/S0165-0270(02)00007-9","journal-title":"J Neurosci Methods"},{"issue":"6","key":"890_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2174\/1566524013363195","volume":"1","author":"S Couillard-Despres","year":"2001","unstructured":"Couillard-Despres S, Winkler J, Uyanik G, Aigner L (2001) Molecular mechanisms of neuronal migration disorders, quo vadis? Curr Mol Med 1(6):677\u2013688. https:\/\/doi.org\/10.2174\/1566524013363195","journal-title":"Curr Mol Med"},{"issue":"1","key":"890_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0092-8674(00)80899-5","volume":"92","author":"JG Gleeson","year":"1998","unstructured":"Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Cooper EC, Dobyns WB et al (1998) Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92(1):63\u201372. https:\/\/doi.org\/10.1016\/S0092-8674(00)80899-5","journal-title":"Cell"},{"issue":"1","key":"890_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1460-9568.2004.03813.x","volume":"21","author":"S Couillard-Despres","year":"2005","unstructured":"Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N, Bogdahn U, Winkler J et al (2005) Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 21(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03813.x","journal-title":"Eur J Neurosci"},{"issue":"1","key":"890_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.10874","volume":"467","author":"JP Brown","year":"2003","unstructured":"Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG (2003) Transient expression of doublecortin during adult neurogenesis. J Comp Neurol 467(1):1\u201310. https:\/\/doi.org\/10.1002\/cne.10874","journal-title":"J Comp Neurol"},{"key":"890_CR43","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KB (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, London","edition":"2"},{"issue":"4","key":"890_CR44","first-page":"387","volume":"87","author":"DA Sholl","year":"1953","unstructured":"Sholl DA (1953) Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87(4):387\u2013406","journal-title":"J Anat"},{"issue":"7","key":"890_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9(7):676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019","journal-title":"Nat Methods"},{"issue":"8","key":"890_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103155","volume":"9","author":"TS Kannangara","year":"2014","unstructured":"Kannangara TS, Bostrom CA, Ratzlaff A, Thompson L, Cater RM, Gil-Mohapel J, Christie BR (2014) Deletion of the NMDA receptor GluN2A subunit significantly decreases dendritic growth in maturing dentate granule neurons. PLoS One 9(8):e103155. https:\/\/doi.org\/10.1371\/journal.pone.0103155","journal-title":"PLoS One"},{"issue":"4","key":"890_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","volume":"132","author":"C Zhao","year":"2008","unstructured":"Zhao C, Deng W, Gage FH (2008) Mechanisms and functional implications of adult neurogenesis. Cell 132(4):645\u2013660","journal-title":"Cell"},{"issue":"2","key":"890_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1242\/dev.00203","volume":"130","author":"G Kempermann","year":"2003","unstructured":"Kempermann G, Gast D, Kronenberg G, Yamaguchi M, Gage FH (2003) Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 130(2):391\u2013399","journal-title":"Development"},{"issue":"3","key":"890_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.nbd.2012.06.026","volume":"48","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W et al (2012) NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease. Neurobiol Dis 48(3):282\u2013289. https:\/\/doi.org\/10.1016\/j.nbd.2012.06.026","journal-title":"Neurobiol Dis"},{"issue":"20","key":"890_CR50","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1523\/JNEUROSCI.5110-12.2013","volume":"33","author":"KB M\u2019Barek","year":"2013","unstructured":"M\u2019Barek KB, Pla P, Orvoen S, Benstaali C, Godin JD, Gardier AM, Saudou F, David DJ et al (2013) Huntingtin mediates anxiety\/depression-related behaviors and hippocampal neurogenesis. J Neurosci 33(20):8608\u20138620. https:\/\/doi.org\/10.1523\/JNEUROSCI.5110-12.2013","journal-title":"J Neurosci"},{"issue":"1","key":"890_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Mar\u0131n C, Rey M, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866(1):257\u2013261","journal-title":"Brain Res"},{"issue":"5","key":"890_CR52","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1073\/pnas.0536856100","volume":"100","author":"W Duan","year":"2003","unstructured":"Duan W, Guo Z, Jiang H, Ware M, Li X-J, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci 100(5):2911\u20132916. https:\/\/doi.org\/10.1073\/pnas.0536856100","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"890_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","volume":"30","author":"W Duan","year":"2008","unstructured":"Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B, Zhao M, Cadet JL et al (2008) Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease. Neurobiol Dis 30(3):312\u2013322. https:\/\/doi.org\/10.1016\/j.nbd.2008.01.015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"890_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95(1):55\u201366. https:\/\/doi.org\/10.1016\/S0092-8674(00)81782-1","journal-title":"Cell"},{"issue":"18","key":"890_CR55","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"A-P Bemelmans","year":"1999","unstructured":"Bemelmans A-P, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999) Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10(18):2987\u20132997. https:\/\/doi.org\/10.1089\/10430349950016393","journal-title":"Hum Gene Ther"},{"issue":"35","key":"890_CR56","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Mart\u00edn-Iba\u00f1ez R, Munoz MT, Mengod G, Ernfors P et al (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24(35):7727\u20137739. https:\/\/doi.org\/10.1523\/JNEUROSCI.1197-04.2004","journal-title":"J Neurosci"},{"issue":"5","key":"890_CR57","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","volume":"9","author":"AP Kells","year":"2004","unstructured":"Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B (2004) AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 9(5):682\u2013688. https:\/\/doi.org\/10.1016\/j.ymthe.2004.02.016","journal-title":"Mol Ther"},{"issue":"1","key":"890_CR58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1073858405284360","volume":"12","author":"NH Woo","year":"2006","unstructured":"Woo NH, Lu B (2006) Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 12(1):43\u201356. https:\/\/doi.org\/10.1177\/1073858405284360","journal-title":"Neuroscientist"},{"issue":"1","key":"890_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molbrainres.2004.12.020","volume":"136","author":"F Karege","year":"2005","unstructured":"Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Mol Brain Res 136(1):29\u201337","journal-title":"Mol Brain Res"},{"issue":"1","key":"890_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1399-5618.2008.00459.x","volume":"10","author":"P Monteleone","year":"2008","unstructured":"Monteleone P, Serritella C, Martiadis V, Maj M (2008) Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord 10(1):95\u2013100. https:\/\/doi.org\/10.1111\/j.1399-5618.2008.00459.x","journal-title":"Bipolar Disord"},{"issue":"6","key":"890_CR61","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","volume":"64","author":"S Sen","year":"2008","unstructured":"Sen S, Duman R, Sanacora G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64(6):527\u2013532","journal-title":"Biol Psychiatry"},{"issue":"1","key":"890_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mp.2009.67","volume":"15","author":"D Taliaz","year":"2010","unstructured":"Taliaz D, Stall N, Dar D, Zangen A (2010) Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 15(1):80\u201392. https:\/\/doi.org\/10.1038\/mp.2009.67","journal-title":"Mol Psychiatry"},{"issue":"3","key":"890_CR63","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S1461145705005766","volume":"9","author":"R Molteni","year":"2006","unstructured":"Molteni R, Calabrese F, Bedogni F, Tongiorgi E, Fumagalli F, Racagni G, Riva MA (2006) Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharmacol 9(3):307\u2013317","journal-title":"Int J Neuropsychopharmacol"},{"key":"890_CR64","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC","edition":"4"},{"issue":"1","key":"890_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0924-977X(92)90035-7","volume":"2","author":"J-L Moreau","year":"1992","unstructured":"Moreau J-L, Jenck F, Martin JR, Mortas P, Haefely W (1992) Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 2(1):43\u201349. https:\/\/doi.org\/10.1016\/0924-977X(92)90035-7","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"890_CR66","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/00008877-199511000-00003","volume":"6","author":"J-L Moreau","year":"1995","unstructured":"Moreau J-L, Scherschlicht R, Jenck F, Martin J (1995) Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6(7):682\u2013687","journal-title":"Behav Pharmacol"},{"issue":"1","key":"890_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0149-7634(05)80164-2","volume":"14","author":"G Vogel","year":"1990","unstructured":"Vogel G, Neill D, Hagler M, Kors D (1990) A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14(1):85\u201391. https:\/\/doi.org\/10.1016\/S0149-7634(05)80164-2","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"890_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","volume":"57","author":"G Griebel","year":"2005","unstructured":"Griebel G, Stemmelin J, Scatton B (2005) Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol Psychiatry 57(3):261\u2013267","journal-title":"Biol Psychiatry"},{"issue":"1","key":"890_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2004.04.008","volume":"155","author":"S Pothion","year":"2004","unstructured":"Pothion S, Bizot J-C, Trovero F, Belzung C (2004) Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behav Brain Res 155(1):135\u2013146. https:\/\/doi.org\/10.1016\/j.bbr.2004.04.008","journal-title":"Behav Brain Res"},{"issue":"4","key":"890_CR70","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29(4):571\u2013625. https:\/\/doi.org\/10.1016\/j.neubiorev.2005.03.009","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"890_CR71","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9(4):326\u2013357. https:\/\/doi.org\/10.1038\/sj.mp.4001457","journal-title":"Mol Psychiatry"},{"issue":"2","key":"890_CR72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","volume":"36","author":"JF Poduslo","year":"1996","unstructured":"Poduslo JF, Curran GL (1996) Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol Brain Res 36(2):280\u2013286. https:\/\/doi.org\/10.1016\/0169-328X(95)00250-V","journal-title":"Mol Brain Res"},{"issue":"12","key":"890_CR73","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood\u2013brain barrier. Neuropharmacology 37(12):1553\u20131561. https:\/\/doi.org\/10.1016\/S0028-3908(98)00141-5","journal-title":"Neuropharmacology"},{"issue":"5","key":"890_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064037","volume":"8","author":"C Giampa","year":"2013","unstructured":"Giampa C, Montagna E, Dato C, Melone MA, Bernardi G, Fusco FR (2013) Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One 8(5):e64037. https:\/\/doi.org\/10.1371\/journal.pone.0064037","journal-title":"PLoS One"},{"issue":"1","key":"890_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2202-5-17","volume":"5","author":"JM Gil","year":"2004","unstructured":"Gil JM, Leist M, Popovic N, Brundin P, Peters\u00e9n \u00c5 (2004) Asialoerythropoetin is not effective in the R6\/2 line of Huntington\u2019s disease mice. BMC Neurosci 5(1):17","journal-title":"BMC Neurosci"},{"issue":"5","key":"890_CR76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","volume":"15","author":"SE Lazic","year":"2004","unstructured":"Lazic SE, Grote H, Armstrong RJ, Blakemore C, Hannan AJ, van Dellen A, Barker RA (2004) Decreased hippocampal cell proliferation in R6\/1 Huntington\u2019s mice. Neuroreport 15(5):811\u2013813","journal-title":"Neuroreport"},{"issue":"7","key":"890_CR77","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1460-9568.2006.04715.x","volume":"23","author":"SE Lazic","year":"2006","unstructured":"Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, Phillips W, Barker RA (2006) Neurogenesis in the R6\/1 transgenic mouse model of Huntington\u2019s disease: effects of environmental enrichment. Eur J Neurosci 23(7):1829\u20131838. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04715.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"890_CR78","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/NEN.0b013e3181e4f733","volume":"69","author":"M Kandasamy","year":"2010","unstructured":"Kandasamy M, Couillard-Despres S, Raber KA, Stephan M, Lehner B, Winner B, Kohl Z, Rivera FJ et al (2010) Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-\u03b2 signaling in an animal model of huntington disease. J Neuropathol Exp Neurol 69(7):717\u2013728. https:\/\/doi.org\/10.1097\/NEN.0b013e3181e4f733","journal-title":"J Neuropathol Exp Neurol"},{"key":"890_CR79","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2011.06.040","volume":"1406","author":"J Gil-Mohapel","year":"2011","unstructured":"Gil-Mohapel J, Simpson JM, Ghilan M, Christie BR (2011) Neurogenesis in Huntington\u2019s disease: can studying adult neurogenesis lead to the development of new therapeutic strategies? Brain Res 1406:84\u2013105. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.040","journal-title":"Brain Res"},{"issue":"3","key":"890_CR80","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","volume":"20","author":"JM Gil","year":"2005","unstructured":"Gil JM, Mohapel P, Ara\u00fajo IM, Popovic N, Li J-Y, Brundin P, Peters\u00e9n \u00c5 (2005) Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice. Neurobiol Dis 20(3):744\u2013751","journal-title":"Neurobiol Dis"},{"issue":"50","key":"890_CR81","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","volume":"25","author":"W Phillips","year":"2005","unstructured":"Phillips W, Morton AJ, Barker RA (2005) Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in vivo microenvironment. J Neurosci 25(50):11564\u201311576. https:\/\/doi.org\/10.1523\/JNEUROSCI.3796-05.2005","journal-title":"J Neurosci"},{"issue":"24","key":"890_CR82","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24):9104\u20139110","journal-title":"J Neurosci"},{"issue":"2","key":"890_CR83","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(01)00989-X","volume":"420","author":"R Manev","year":"2001","unstructured":"Manev R, Uz T, Manev H (2001) Fluoxetine increases the content of neurotrophic protein S100\u03b2 in the rat hippocampus. Eur J Pharmacol 420(2):R1\u2013R2. https:\/\/doi.org\/10.1016\/S0014-2999(01)00989-X","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"890_CR84","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/npp.2009.75","volume":"34","author":"M Boldrini","year":"2009","unstructured":"Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, Mann JJ, Arango V (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34(11):2376\u20132389. https:\/\/doi.org\/10.1038\/npp.2009.75","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"890_CR85","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.clinpsy.121208.131438","volume":"6","author":"GA Marlatt","year":"2010","unstructured":"Marlatt GA, Witkiewitz K (2010) Update on harm-reduction policy and intervention research. Annu Rev Clin Psychol 6(1):591\u2013606. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131438","journal-title":"Annu Rev Clin Psychol"},{"issue":"6","key":"890_CR86","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/0896-6273(89)90040-8","volume":"2","author":"Y-A Barde","year":"1989","unstructured":"Barde Y-A (1989) Trophic factors and neuronal survival. Neuron 2(6):1525\u20131534. https:\/\/doi.org\/10.1016\/0896-6273(89)90040-8","journal-title":"Neuron"},{"issue":"5153","key":"890_CR87","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1126\/science.7907431","volume":"263","author":"A Ghosh","year":"1994","unstructured":"Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science (New York, NY) 263(5153):1618\u20131624","journal-title":"Science (New York, NY)"},{"issue":"1","key":"890_CR88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.coph.2003.10.004","volume":"4","author":"E Castren","year":"2004","unstructured":"Castren E (2004) Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4(1):58\u201364. https:\/\/doi.org\/10.1016\/j.coph.2003.10.004","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"890_CR89","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/mcne.1998.0684","volume":"11","author":"T Zigova","year":"1998","unstructured":"Zigova T, Pencea V, Wiegand SJ, Luskin MB (1998) Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci 11(4):234\u2013245. https:\/\/doi.org\/10.1006\/mcne.1998.0684","journal-title":"Mol Cell Neurosci"},{"issue":"12","key":"890_CR90","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1111\/j.1460-9568.2007.05625.x","volume":"25","author":"RA Henry","year":"2007","unstructured":"Henry RA, Hughes SM, Connor B (2007) AAV-mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid-lesioned adult rat brain. Eur J Neurosci 25(12):3513\u20133525. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05625.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"890_CR91","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.expneurol.2004.11.016","volume":"192","author":"H Scharfman","year":"2005","unstructured":"Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S (2005) Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol 192(2):348\u2013356. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.016","journal-title":"Exp Neurol"},{"issue":"6","key":"890_CR92","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/dev.20546","volume":"54","author":"KG Bath","year":"2012","unstructured":"Bath KG, Akins MR, Lee FS (2012) BDNF control of adult SVZ neurogenesis. Dev Psychobiol 54(6):578\u2013589. https:\/\/doi.org\/10.1002\/dev.20546","journal-title":"Dev Psychobiol"},{"issue":"3\u20134","key":"890_CR93","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0361-9230(01)00598-6","volume":"56","author":"Q Chu-LaGraff","year":"2001","unstructured":"Chu-LaGraff Q, Kang X, Messer A (2001) Expression of the Huntington\u2019s disease transgene in neural stem cell cultures from R6\/2 transgenic mice. Brain Res Bull 56(3\u20134):307\u2013312. https:\/\/doi.org\/10.1016\/S0361-9230(01)00598-6","journal-title":"Brain Res Bull"},{"issue":"2","key":"890_CR94","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2011.04.009","volume":"43","author":"AG Walker","year":"2011","unstructured":"Walker AG, Ummel JR, Rebec GV (2011) Reduced expression of conditioned fear in the R6\/2 mouse model of Huntington\u2019s disease is related to abnormal activity in prelimbic cortex. Neurobiol Dis 43(2):379\u2013387. https:\/\/doi.org\/10.1016\/j.nbd.2011.04.009","journal-title":"Neurobiol Dis"},{"issue":"51","key":"890_CR95","doi-asserted-by":"publisher","first-page":"21900","DOI":"10.1073\/pnas.0912171106","volume":"106","author":"AE Molero","year":"2009","unstructured":"Molero AE, Gokhan S, Gonzalez S, Feig JL, Alexandre LC, Mehler MF (2009) Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington\u2019s disease. Proc Natl Acad Sci 106(51):21900\u201321905. https:\/\/doi.org\/10.1073\/pnas.0912171106","journal-title":"Proc Natl Acad Sci"},{"key":"890_CR96","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2014.06.011","volume":"1581","author":"M Ghilan","year":"2014","unstructured":"Ghilan M, Bostrom CA, Hryciw BN, Simpson JM, Christie BR, Gil-Mohapel J (2014) YAC128 Huntington\u2019s disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease. Brain Res 1581:117\u2013128. https:\/\/doi.org\/10.1016\/j.brainres.2014.06.011","journal-title":"Brain Res"},{"issue":"1\u20132","key":"890_CR97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","volume":"213","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213(1\u20132):93\u2013118. https:\/\/doi.org\/10.1007\/s00429-008-0189-x","journal-title":"Brain Struct Funct"},{"issue":"2","key":"890_CR98","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2011.11.063","volume":"507","author":"S Orvoen","year":"2012","unstructured":"Orvoen S, Pla P, Gardier AM, Saudou F, David DJ (2012) Huntington\u2019s disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci Lett 507(2):127\u2013132","journal-title":"Neurosci Lett"},{"issue":"10","key":"890_CR99","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","volume":"19","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice. Eur J Neurosci 19(10):2799\u20132807. https:\/\/doi.org\/10.1111\/j.0953-816X.2004.03374.x","journal-title":"Eur J Neurosci"},{"issue":"3","key":"890_CR100","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/JGP.0b013e318196a632","volume":"17","author":"J Nithianantharajah","year":"2009","unstructured":"Nithianantharajah J, Barkus C, Vijiaratnam N, Clement O, Hannan AJ (2009) Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington\u2019s disease transgenic mice. Am J Geriatr Psychiatry 17(3):196\u2013209","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"890_CR101","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00429-011-0340-y","volume":"217","author":"N Heck","year":"2012","unstructured":"Heck N, Betuing S, Vanhoutte P, Caboche J (2012) A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington\u2019s disease. Brain Struct Funct 217(2):421\u2013434. https:\/\/doi.org\/10.1007\/s00429-011-0340-y","journal-title":"Brain Struct Funct"},{"issue":"32","key":"890_CR102","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","volume":"33","author":"RP Murmu","year":"2013","unstructured":"Murmu RP, Li W, Holtmaat A, Li JY (2013) Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington\u2019s disease. J Neurosci 33(32):12997\u201313009. https:\/\/doi.org\/10.1523\/JNEUROSCI.5284-12.2013","journal-title":"J Neurosci"},{"issue":"2","key":"890_CR103","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JHD-120024","volume":"1","author":"SJ Bulley","year":"2012","unstructured":"Bulley SJ, Drew CJ, Morton AJ (2012) Direct visualisation of abnormal dendritic spine morphology in the hippocampus of the R6\/2 transgenic mouse model of Huntington\u2019s disease. J Huntingtons Dis 1(2):267\u2013273. https:\/\/doi.org\/10.3233\/JHD-120024","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"890_CR104","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneumeth.2007.12.006","volume":"169","author":"CA Chapleau","year":"2008","unstructured":"Chapleau CA, Carlo ME, Larimore JL, Pozzo-Miller L (2008) The actions of BDNF on dendritic spine density and morphology in organotypic slice cultures depend on the presence of serum in culture media. J Neurosci Methods 169(1):182\u2013190. https:\/\/doi.org\/10.1016\/j.jneumeth.2007.12.006","journal-title":"J Neurosci Methods"},{"issue":"3","key":"890_CR105","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11689-009-9027-6","volume":"1","author":"CA Chapleau","year":"2009","unstructured":"Chapleau CA, Larimore JL, Theibert A, Pozzo-Miller L (2009) Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodev Disord 1(3):185\u2013196. https:\/\/doi.org\/10.1007\/s11689-009-9027-6","journal-title":"J Neurodev Disord"},{"key":"890_CR106","doi-asserted-by":"publisher","unstructured":"Kellner Y, Godecke N, Dierkes T, Thieme N, Zagrebelsky M, Korte M (2014) The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity. Front Synaptic Neurosci 6(5). https:\/\/doi.org\/10.3389\/fnsyn.2014.00005","DOI":"10.3389\/fnsyn.2014.00005"},{"issue":"3","key":"890_CR107","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0306-4522(02)00301-9","volume":"114","author":"RJ Tolwani","year":"2002","unstructured":"Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM (2002) BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 114(3):795\u2013805. https:\/\/doi.org\/10.1016\/S0306-4522(02)00301-9","journal-title":"Neuroscience"},{"issue":"5","key":"890_CR108","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1073\/pnas.0536856100","volume":"100","author":"W Duan","year":"2003","unstructured":"Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP (2003) Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A 100(5):2911\u20132916. https:\/\/doi.org\/10.1073\/pnas.0536856100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"890_CR109","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbr.2017.07.034","volume":"334","author":"C Vanzella","year":"2017","unstructured":"Vanzella C, Neves JD, Vizuete AF, Aristimunha D, Kolling J, Longoni A, Gon\u00e7alves CAS, Wyse ATS et al (2017) Treadmill running prevents age-related memory deficit and alters neurotrophic factors and oxidative damage in the hippocampus of Wistar rats. Behav Brain Res 334:78\u201385. https:\/\/doi.org\/10.1016\/j.bbr.2017.07.034","journal-title":"Behav Brain Res"},{"key":"890_CR110","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2017.09.047","volume":"661","author":"K Yagishita","year":"2017","unstructured":"Yagishita K, Suzuki R, Mizuno S, Katoh-Semba R, Sadakata T, Sano Y, Furuichi T, Shinoda Y (2017) CAPS2 deficiency affects environmental enrichment-induced adult neurogenesis and differentiation\/survival of newborn neurons in the hippocampal dentate gyrus. Neurosci Lett 661:121\u2013125. https:\/\/doi.org\/10.1016\/j.neulet.2017.09.047","journal-title":"Neurosci Lett"},{"issue":"Pt A","key":"890_CR111","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.expneurol.2016.08.012","volume":"285","author":"C Reick","year":"2016","unstructured":"Reick C, Ellrichmann G, Tsai T, Lee DH, Wiese S, Gold R, Saft C, Linker RA (2016) Expression of brain-derived neurotrophic factor in astrocytes - beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington\u2019s disease. Exp Neurol 285(Pt A):12\u201323. https:\/\/doi.org\/10.1016\/j.expneurol.2016.08.012","journal-title":"Exp Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0890-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T15:34:24Z","timestamp":1660404864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":111,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0890-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"14 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}